Health in Malaysia 1,084 indicators covering health for Malaysia. IndicatorLatest Year10-yr change Rank The number of people with susceptibility test result for rifampicin 84.34 2021 — 86th Number of presumed malaria cases 0 2024 — 40th Number of indigenous malaria cases 0 2024 down 100.0% 82nd Number of confirmed malaria cases 2,384 2024 up 3.2% 70th Total number of malaria cases 2,384 2024 up 3.2% 70th Retreatment cases: treatment after default 281 2012 up 60.6% 31st Number of indigenous P. falciparum malaria cases 0 2024 down 100.0% 75th Number of suspected malaria cases 875,712 2024 down 17.9% 46th Retreatment cases: other 535 2012 up 806.8% 38th Retreatment cases: treatment after failure 43 2012 up 115.0% 70th Number of malaria positive cases by microscopy 2,384 2024 up 3.2% 63rd Number of malaria suspects examined by microscopy 875,712 2024 down 17.9% 22nd Absolute number of deaths from ambient particulate air pollution 9,500 2015 up 18.8% 49th Tuberculosis funding versus budget requirement 17.42 million 2025 up 9.0% 18th Antenatal care attendees who were positive for syphilis (%), reported 0.1% 2024 up 83.3% 79th Percentage of people living with HIV who have suppressed viral loads 55 2025 up 14.6% 72nd Percentage of people living with HIV receiving treatment who have 88 2025 up 3.5% 76th Number of reported deaths from cholera 2 2015 — 36th Domestic Expenditure on Malaria 46.93 million 2024 down 43.6% 6th Laboratories providing tuberculosis diagnostic services using culture 6.5 2014 up 3,150.0% 55th Laboratories providing tuberculosis diagnostic services using sputum 2.6 2014 up 188.9% 24th Congenital syphilis number of cases, reported 41 2024 up 41.4% 24th Average cost of tuberculosis treatment multi drug resistant 2,000 2024 unchanged 22nd Completeness of death registration with cause-of-death information 52.0% 2014 up 4.8% 87th Congenital syphilis rate per 100 000 live births, reported 10.63 2024 up 59.8% 34th Nursing personnel 95.1% 2024 down 1.2% 11th Health worker distribution, by sex and type of occupation 95.1% 2024 down 1.2% 11th Treatment success rate: XDR-TB cases 80 2022 — 24th Participation rate in organized learning (one year before the) 98.6% 2015 up 34.5% 17th Antenatal care attendees positive for syphilis who received treatment 95.2% 2024 down 4.8% 40th Hpv vaccination coverage in 15 year olds 77 2024 down 10.5% 33rd Prevalence of syphilis 0.1% 2022 down 57.1% 78th Sales of beer in 1000s hectolitres 1.33 2009 down 9.5% 158th Confirmed cases of MDR-TB 74 2012 up 7,300.0% 47th New cases: other 0 2012 — 33rd Compliance with international health regulations 100 2016 up 9.9% 1st Number of malaria cases treated with any first line tx courses 3,628 2023 — 59th Number of disruptions to health services attributed to disasters 234 2024 up 59.2% 2nd Number of indigenous P. vivax malaria cases 0 2024 down 100.0% 39th Deaths and disappearances during migration 5 2024 down 90.9% 48th Number of imported malaria cases 398 2024 down 8.5% 16th Number of malaria cases treated with artemisinin-based combination 3,626 2023 — 52nd Number of people protected from malaria by indoor residual spraying 99,553 2023 down 79.6% 35th Number of destroyed or damaged health facilities attributed to 13 2024 down 59.4% 14th Average cost of tuberculosis treatment by type 35 2024 up 1,650.0% 15th Pharmaceutical Technicians and Assistants 4,956 2024 down 1.6% 12th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 7.4% 2014 — 94th Medical and Pathology Laboratory Technicians 8,983 2024 up 40.4% 8th Proportion of bloodstream infection due to Escherichia coli resistant 27.2% 2023 down 0.7% 33rd Dental Assistants and Therapists 7,618 2023 up 13.1% 6th Proportion of bloodstream infection due to methicillin-resistant 19.6% 2023 down 10.5% 32nd Environmental and Occupational Health and Hygiene Professionals 307 2024 up 52.7% 18th Commitments to recipient countries 0.66 2010 down 7.0% 116th Disbursements to recipient countries 0.67 2010 down 83.6% 116th Medical and Pathology Laboratory scientists 2,701 2024 up 112.7% 8th Reported cases of urethral discharge among men 2,479 2023 up 95.7% 28th Imports in 1000s hectolitres 41 2007 down 25.5% 76th Dental Prosthetic Technicians 1,206 2024 down 33.8% 5th Number of isolates tested for ceftriaxone 132 2020 up 1,220.0% 23rd Proportion of isolates with decreased susceptibility or resistance 6.8 2020 down 32.0% 3rd ← Previous Page 18 of 19 Next →